These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 3973012

  • 21. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.
    Diczfalusy U, Kase BF, Alexson SE, Björkhem I.
    J Clin Invest; 1991 Sep; 88(3):978-84. PubMed ID: 1885782
    [Abstract] [Full Text] [Related]

  • 22. Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes.
    Kase F, Björkhem I, Pedersen JI.
    J Lipid Res; 1983 Dec; 24(12):1560-7. PubMed ID: 6668450
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Competitive inhibition of side chain oxidation of 3 alpha, 7 alpha-dihydroxy-5 beta-cholestan-26-oic acid by 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestan-26-oic acid in the hamster.
    Cass OW, Williams GC, Hanson RF.
    J Lipid Res; 1980 Feb; 21(2):186-91. PubMed ID: 7373160
    [Abstract] [Full Text] [Related]

  • 25. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G, Shefer S, Tint GS, Nicolau G, Dayal B, Batta AK.
    J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
    [Abstract] [Full Text] [Related]

  • 26. Formation of varanic acid, 3 alpha, 7 alpha, 12 alpha, 24-tetrahydroxy-5 beta-cholestanoic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid in Bombina orientalis.
    Une M, Inoue A, Hoshita T.
    Steroids; 1996 Nov; 61(11):639-41. PubMed ID: 8916357
    [Abstract] [Full Text] [Related]

  • 27. Effect of the side-chain structure on the specificity of beta-oxidation in bile acid biosynthesis in rat liver homogenates.
    Kurosawa T, Sato M, Watanabe T, Suga T, Tohma M.
    J Lipid Res; 1997 Dec; 38(12):2589-602. PubMed ID: 9458282
    [Abstract] [Full Text] [Related]

  • 28. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy.
    Setchell KD, Heubi JE, Bove KE, O'Connell NC, Brewsaugh T, Steinberg SJ, Moser A, Squires RH.
    Gastroenterology; 2003 Jan; 124(1):217-32. PubMed ID: 12512044
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hepatic lesions and hemolysis following administration of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oyl taurine to rats.
    Hanson RF, Williams GC, Hachey D, Sharp HL.
    J Lab Clin Med; 1977 Sep; 90(3):536-48. PubMed ID: 894105
    [Abstract] [Full Text] [Related]

  • 31. Identification of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholest-24-enoic acid as an intermediate in the peroxisomal conversion of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid to cholic acid.
    Ostlund Farrants AK, Björkhem I, Pedersen JI.
    Biochim Biophys Acta; 1989 Apr 03; 1002(2):198-202. PubMed ID: 2930767
    [Abstract] [Full Text] [Related]

  • 32. [Liver pathologies due to peroxisome disorders].
    Lovisetto P, Raviolo P.
    Recenti Prog Med; 1994 Feb 03; 85(2):134-41. PubMed ID: 8184191
    [Abstract] [Full Text] [Related]

  • 33. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S, Björkhem I, Buchmann MS, Hopen G, Fausa O.
    J Clin Invest; 1985 Feb 03; 75(2):448-55. PubMed ID: 3919058
    [Abstract] [Full Text] [Related]

  • 34. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.
    Oftebro H, Björkhem I, Skrede S, Schreiner A, Pederson JI.
    J Clin Invest; 1980 Jun 03; 65(6):1418-30. PubMed ID: 7410549
    [Abstract] [Full Text] [Related]

  • 35. Stereoisomeric inversion of (25R)- and (25S)-3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acids in rat liver peroxisome.
    Ikegawa S, Goto T, Watanabe H, Goto J.
    Biol Pharm Bull; 1995 Jul 03; 18(7):1027-9. PubMed ID: 7581245
    [Abstract] [Full Text] [Related]

  • 36. Inborn errors of bile acid metabolism.
    Clayton PT.
    J Inherit Metab Dis; 1991 Jul 03; 14(4):478-96. PubMed ID: 1749214
    [Abstract] [Full Text] [Related]

  • 37. Substrate stereospecificity in oxidation of (25S)-3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoyl-CoA by peroxisomal trihydroxy-5 beta-cholestanoyl-CoA oxidase.
    Pedersen JI, Veggan T, Björkhem I.
    Biochem Biophys Res Commun; 1996 Jul 05; 224(1):37-42. PubMed ID: 8694830
    [Abstract] [Full Text] [Related]

  • 38. Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid in human skin fibroblasts.
    Une M, Izumi N, Imanaka T, Hoshita T.
    J Biochem; 1992 Nov 05; 112(5):576-7. PubMed ID: 1478914
    [Abstract] [Full Text] [Related]

  • 39. Effect of taurocholate on the conversion of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oic acid into cholic acid.
    Hanson RF, Williams GC.
    Steroids; 1978 Jun 05; 31(6):809-13. PubMed ID: 694969
    [Abstract] [Full Text] [Related]

  • 40. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid.
    Axelson M, Ellis E, Mörk B, Garmark K, Abrahamsson A, Björkhem I, Ericzon BG, Einarsson C.
    Hepatology; 2000 Jun 05; 31(6):1305-12. PubMed ID: 10827156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.